Ownership Structure

Transparent equity distribution and cap table for Bio-Stride

Current Equity Distribution

Pre-seed stage cap table

Company Overview

Company Status Being Registered
Total Shares Authorized 10,000,000
Shares Outstanding 1,000,000
Current Valuation Pre-money TBD
Stage Pre-seed
ESOP Pool 10% (Reserved)

📊
Capitalization Table

Shareholder Class Shares Percentage Vesting Status
Anagh Sinha
Founder & CEO 		Common 900,000 90%
4-year vesting
1-year cliff		 Active
Employee Stock Option Pool
Reserved for team 		Common 100,000 10%
Individual grants Reserved
Pre-seed Investors
To be allocated 		Preferred TBD ~10-15%
N/A Fundraising

⏱️
Founder Vesting Schedule

Start
July 2025
Cliff (25%)
July 2026
50% Vested
July 2027
75% Vested
July 2028
Fully Vested
July 2029

Standard 4-year vesting with 1-year cliff ensures long-term commitment to Bio-Stride's mission

💼
Equity Structure Details

Founder Equity

90%
Share Class Common Stock
Vesting Period 4 years
Cliff Period 1 year
Acceleration Double trigger

ESOP Pool

10%
Reserved For Key Employees
Exercise Price Fair Market Value
Vesting 4 years standard
Allocation Plan Board Approved

Future Rounds

TBD
Pre-seed Target 10-15%
Seed Target 15-20%
Series A Target 20-25%
Pro-rata Rights Major Investors

🚀
Investment Status

💰

Raising Pre-seed Round

Bio-Stride is currently raising ₹49 lakhs in pre-seed funding to develop our deployment-ready TBI detection system and hire founding engineers. Join us in revolutionizing emergency diagnostics in India.

Contact for Investment